Cite
HARVARD Citation
YAMAGUCHI, O. et al. (2015). Efficacy and Safety of the Selective β3‐Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Finding Study. LUTS. 7 (2), pp. 84-92. [Online].